Leveraging AlphaFold2 structural space exploration for generating drug target structures in structure-based virtual screening
Computational virtual screening (VS) plays a vital role in early-stage drug discovery by enabling the efficient selection of candidate compounds and reducing associated costs. However, the absence of experimentally determined three-dimensional protein structures often limits the applicability of str...
Saved in:
| Main Authors: | Keisuke Uchikawa, Kairi Furui, Masahito Ohue |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Biochemistry and Biophysics Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405580825001979 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An outlook on structural biology after AlphaFold: tools, limits and perspectives
by: Serena Rosignoli, et al.
Published: (2025-02-01) -
Bridging prediction and reality: Comprehensive analysis of experimental and AlphaFold 2 full-length nuclear receptor structures
by: Akerke Mazhibiyeva, et al.
Published: (2025-01-01) -
Comprehensive assessment of AlphaFold’s predictions of secondary structure and solvent accessibility at the amino acid-level in eukaryotic, bacterial and archaeal proteins
by: Jing Yu, et al.
Published: (2025-01-01) -
Identification of novel compounds against Trypanosoma cruzi using AlphaFold structures
by: Albert Ros-Lucas, et al.
Published: (2025-01-01) -
Evaluation of the structural models of the human reference proteome: AlphaFold2 versus ESMFold
by: Matteo Manfredi, et al.
Published: (2025-06-01)